miRagen Therapeutics Named to FierceBiotech’s 2012 Fierce 15 List of Most Promising Private Biotechnology Companies

BOULDER, Colo.--(BUSINESS WIRE)--FierceBiotech today named miRagen Therapeutics as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth annual Fierce 15 selection.